| 產(chǎn)品名稱 | MBX 2982 |
| 產(chǎn)品貨號 | Axon 2092 CAS [1037792-44-1] MF C22H24N8OSMW 448.54 Purity: 98% Soluble in DMSO Description Potent and selective agonist of G-protein coupled receptor 119 (GPR119); an orally active agent to treat type 2 diabetes; MBX 2982 acts directly on the β cell to increase insulin secretion. In addition, it stimulates release of the incretin GLP-1 from the gut References Certificates Categories Extra info J Seewoodhary and SC Bain. Novel treatments for type 2 diabetes. Br. J. Gen. Pract. 2011, 61(582): 5–6.? ? RM Jones et al. GPR119 agonists for the treatment of type 2 diabetes. Exp. Opin. Ther. Pat. 2009, 19(10), 1339-1359.? Certificate of Analysis Material Safety Data Sheet CNS Diabetes & Metabolism Endocrinology GPR119 A15 Potent and selective GPR119 agonist Chemical name 4-((4-(1H-tetrazol-1-yl)phenyl1H-tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole Parent CAS No. [1037792-44-1] Order Size Unit Price Stock 5 mg €125.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
MBX 2982Axon 2092 CAS [1037792-44-1] MF C22H24N8OS
Description
Potent and selective agonist of G-protein coupled receptor 119 (GPR119); an orally active agent to treat type 2 diabetes; MBX 2982 acts directly on the β cell to increase insulin secretion. In addition, it stimulates release of the incretin GLP-1 from the gut
Potent and selective GPR119 agonist
Chemical name4-((4-(1H-tetrazol-1-yl)phenyl1H-tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole Parent CAS No.[1037792-44-1] |
| 產(chǎn)品資料 |
